Mental Health Clinics in Sayville, NY Accepting Medicare
8 Mental Health Clinics found. Showing 1 - 8
 Lodestar Children's Services Inc. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 259 Versa Pl, Sayville, NY 11782 Phone: 631-767-1589 |
Wholehearted Living Lcsw Pc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 23 Candee Avenue, Sayville, NY 11782 Phone: 914-400-5199 |
Miguel A Delgado Md Pc Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 29 Lowell Rd, Sayville, NY 11782 Phone: 516-983-5118 Fax: 631-728-4749 |
Adrian Fields Lmhc And Associates, Pllc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 17 Main St, Sayville, NY 11782 Phone: 631-885-1212 |
Jennifer Flanagan Lcsw, Pc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 296 N Main St, Suite One, Sayville, NY 11782 Phone: 631-472-2629 |
Psychological Health Care Of Islip, P.c. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 100 S Main St, Suite 206, Sayville, NY 11782 Phone: 631-277-4080 Fax: 631-288-1115 |
Christopher Probeyahn Lcsw Pllc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 100 S Main St Ste 204, Sayville, NY 11782 Phone: 631-942-6921 |
Suffolk Counseling Services Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 23 Candee Ave, Sayville, NY 11782 Phone: 855-552-9355 Fax: 855-552-9355 |
News Archive
Deakin University has been given World Health Organisation (WHO) Collaborating Centre status
Deakin University, Australia has been given World Health Organisation (WHO) Collaborating Centre status for research into obesity prevention and related nutrition and physical activity programs.
Innovative technology could treat cancer more selectively and effectively
Treating cancer more selectively and more effectively - this could be achieved with an innovative technology developed by teams of researchers at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie and the Ludwig-Maximilians-Universität München.
GE Healthcare to present anti-[18F]FACBC phase 1 study results at Society of Nuclear Medicine annual meeting
GE Healthcare, a unit of the General Electric Company, today will present results of a phase 1 study of anti-[18F]FACBC at the 57th annual meeting of the Society of Nuclear Medicine in Salt Lake City, Utah. The presentation closely follows the launch of the phase 2 clinical development program for anti-[18F]FACBC, which was initially discovered and developed by Emory University, Atlanta, Georgia, and was licensed to Nihon Medi-Physics Co., Ltd. (NMP) of Japan.
Anacor finds novel mechanism for lead anti-fungal drug, AN2690
Anacor Pharmaceuticals, a privately held pharmaceutical company, has announced that the journal Science will publish results of research that details how AN2690, the company's lead clinical candidate, kills fungal cells by interfering with synthesis of a specific protein required for fungal growth.
Study provides evidence that crucial brain region plays key role in converting vision into action
You see the flour in the pantry, so you reach for it. You see the traffic light change to green, so you step on the gas. While the link between seeing and then moving in response is simple and essential to everyday existence, neuroscientists haven't been able to get beyond debating where the link is and how it's made.
› Verified 6 days ago